Platelet-Rich Plasma: Are the Obtaining Methods, Classification and Clinical Outcome Always Connected?

Click to increase image sizeClick to decrease image size

Acknowledgments

Each co-author listed above participated sufficiently in the work to take responsibility for the content, and that all those who qualify are listed. All authors: have substantial contributions to the conception and design of the work; drafting the work and revising it critically for important intellectual content; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Financial & competing interests disclosure

The authors declare that E Anitua is the Scientific Director of, and S Padilla, R Prado and MH Alkhraisat are scientists at, BTI Biotechnology Institute, a biomedical company that investigates in the fields of regenerative medicine and PRGF-Endoret technology. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.